ES2149341T3 - Expulsion de un material a partir de un dispositivo de liberacion. - Google Patents

Expulsion de un material a partir de un dispositivo de liberacion.

Info

Publication number
ES2149341T3
ES2149341T3 ES95903880T ES95903880T ES2149341T3 ES 2149341 T3 ES2149341 T3 ES 2149341T3 ES 95903880 T ES95903880 T ES 95903880T ES 95903880 T ES95903880 T ES 95903880T ES 2149341 T3 ES2149341 T3 ES 2149341T3
Authority
ES
Spain
Prior art keywords
active substance
release device
expulsion
hydrogel
release
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES95903880T
Other languages
English (en)
Inventor
Howard Norman Ernest Stevens
Abdul Rashid
Massoud Bakhshaee
Julie Stephanie Binns
Christopher Jon Miller
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Catalent Pharma Solutions Inc
Original Assignee
Catalent Pharma Solutions Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Catalent Pharma Solutions Inc filed Critical Catalent Pharma Solutions Inc
Application granted granted Critical
Publication of ES2149341T3 publication Critical patent/ES2149341T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4866—Organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4808—Preparations in capsules, e.g. of gelatin, of chocolate characterised by the form of the capsule or the structure of the filling; Capsules containing small tablets; Capsules with outer layer for immediate drug release
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Preparation (AREA)
  • Materials For Medical Uses (AREA)

Abstract

UN DISPOSITIVO DE LIBERACION PARA SUMINISTRAR UNA SUSTANCIA ACTIVA (12) A UN PACIENTE EN UN MOMENTO PREDETERMINADO DESPUES DE LA ADMINISTRACION, QUE CONSTA DE UN ENCHUFE DE HIDROGEL MACHO (2) CONECTADO AL CUELLO (4) DE UN CUERPO HEMBRA (6). SE PROPORCIONA UN EXCIPIENTE EXPANDIBLE (10) COMO UN POLVO DE HIDROGEL O UN DESINTEGRANTE FARMACEUTICO EN POLVO, EN FORMA ACUOSA O TABLETA, POR DEBAJO DE LA SUSTANCIA ACTIVA. EN CONTACTO CON UN MEDIO ACUOSO, EL EXCIPIENTE ABSORBE EL AGUA Y SE ENGROSA PARA EXPULSAR RAPIDAMENTE LA SUSTANCIA ACTIVA Y LIBERARLA EFICAZMENTE DESDE EL DISPOSITIVO.
ES95903880T 1993-12-23 1994-12-22 Expulsion de un material a partir de un dispositivo de liberacion. Expired - Lifetime ES2149341T3 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB939326267A GB9326267D0 (en) 1993-12-23 1993-12-23 Expulsion of material
PCT/GB1994/002793 WO1995017172A1 (en) 1993-12-23 1994-12-22 Expulsion of material from a delivery device

Publications (1)

Publication Number Publication Date
ES2149341T3 true ES2149341T3 (es) 2000-11-01

Family

ID=10747079

Family Applications (1)

Application Number Title Priority Date Filing Date
ES95903880T Expired - Lifetime ES2149341T3 (es) 1993-12-23 1994-12-22 Expulsion de un material a partir de un dispositivo de liberacion.

Country Status (8)

Country Link
US (1) US5897874A (es)
EP (1) EP0735865B1 (es)
JP (1) JPH09507058A (es)
AU (1) AU1278195A (es)
DE (1) DE69425275T2 (es)
ES (1) ES2149341T3 (es)
GB (1) GB9326267D0 (es)
WO (1) WO1995017172A1 (es)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4100910B2 (ja) * 1999-12-23 2008-06-11 ファイザー・プロダクツ・インク ヒドロゲル駆動の薬物剤形
US6669954B2 (en) 2000-01-25 2003-12-30 John R. Crison Controlled release of drugs
CA2448558A1 (en) * 2001-07-10 2003-01-23 Teva Pharmaceutical Industries, Ltd. Drug delivery system for zero order, zero order-biphasic, ascending or descending drug delivery
CA2409552A1 (en) * 2001-10-25 2003-04-25 Depomed, Inc. Gastric retentive oral dosage form with restricted drug release in the lower gastrointestinal tract
US20030152622A1 (en) * 2001-10-25 2003-08-14 Jenny Louie-Helm Formulation of an erodible, gastric retentive oral diuretic
US20030091630A1 (en) * 2001-10-25 2003-05-15 Jenny Louie-Helm Formulation of an erodible, gastric retentive oral dosage form using in vitro disintegration test data
US20030104052A1 (en) * 2001-10-25 2003-06-05 Bret Berner Gastric retentive oral dosage form with restricted drug release in the lower gastrointestinal tract
MXPA05000206A (es) * 2002-06-28 2005-12-05 Johnson & Johnson Forma de dosificiacion oral que comprende una formulacion liquida de agente activo y liberacion controlada de la misma mediante una composicion osmotica expansible.
US7350479B2 (en) * 2004-09-10 2008-04-01 United States Of America As Represented By The Secretary Of The Army System and method for controlling growth of aquatic plants utilizing bio-eroding means implanted in triploid grass carp
WO2008140461A1 (en) * 2007-05-16 2008-11-20 Fmc Corporation Solid form
US20080286344A1 (en) * 2007-05-16 2008-11-20 Olivia Darmuzey Solid form
CA2780274C (en) 2009-11-09 2018-06-26 Spotlight Technology Partners Llc Fragmented hydrogels
CA2780294C (en) 2009-11-09 2018-01-16 Spotlight Technology Partners Llc Polysaccharide based hydrogels
EP3069708B1 (en) * 2011-10-06 2018-05-09 Combocap, Inc. Capsule
US9456987B2 (en) 2013-04-03 2016-10-04 Binutra, Inc. Capsule with internal diaphragm

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4327725A (en) * 1980-11-25 1982-05-04 Alza Corporation Osmotic device with hydrogel driving member
GB8903564D0 (en) * 1989-02-16 1989-04-05 Rashid Abdul Drug dispensing device
US5342624A (en) * 1989-02-16 1994-08-30 British Technology Group Ltd. Dispensing device
US5279607A (en) * 1991-05-30 1994-01-18 The State University Of New York Telemetry capsule and process

Also Published As

Publication number Publication date
WO1995017172A1 (en) 1995-06-29
AU1278195A (en) 1995-07-10
MX9500174A (es) 1998-10-31
DE69425275T2 (de) 2001-01-18
JPH09507058A (ja) 1997-07-15
EP0735865A1 (en) 1996-10-09
DE69425275D1 (de) 2000-08-17
EP0735865B1 (en) 2000-07-12
GB9326267D0 (en) 1994-02-23
US5897874A (en) 1999-04-27

Similar Documents

Publication Publication Date Title
ES2149341T3 (es) Expulsion de un material a partir de un dispositivo de liberacion.
PT795324E (pt) Comprimido farmaceutico caracterizado por apresentar um elevado aumento volumerico quando colocado em contacto com fluidos biologicos
ATE167390T1 (de) Vorrichtung zur kontrollierten freigabe
UA42061C2 (uk) Фармацевтична композиція для перорального введення, що містить інгібітори протонного насоса
ES2039758T3 (es) Septum para dispositivos susceptibles de ser implantados para la administracion de sustancias.
AU610112B2 (en) Tablet for pharmaceutical use able to release active substances at successive times
BR9917012A (pt) Comprimido matricial, permitindo a liberação prolongada de gliclazida, após administração por via oral
HU9600572D0 (en) Medicament for inhibiting gastric acid secretion, multiple unit tablated dosage form
HK12495A (en) Pharmaceutical formulations
NL990011I1 (nl) Azelastine bevattende geneesmiddelen voor toepassing in de neus en/of aan het oog.
YU33099A (sh) Farmaceutska smesa za poboljšanje erektilne disfunkcije kod muškaraca
EP0355470A3 (en) Pharmaceutical form with sustained release, and process for its preparation
AR028299A1 (es) Una composicion farmaceutica que comprende nateglinida, un proceso para su preparacion y el uso de dicha composicion para la preparacion de un medicamento para el tratamiento de desordenes metabolicos, especialmente diabetes, o de una enfermedad o condicion asociada con diabetes.
AR065073A2 (es) Una formulacion medicamentosa de sistema de matriz que tiene liberacion controlada de un compuesto activo
PT768867E (pt) Forma de dosagem para a administracao de droga em formulacao liquida
ITMI20020514A1 (it) Sistema terapeutico per il rilascio controllato di uno o piu' principi attivi
PE8298A1 (es) Tabletas exentas de aglutinante que contienen tramadol o una sal de tramadol para administracion oral
ITMI921022A1 (it) Procedimento per la preparazione di una forma liquida stabile di medicamenti contenenti beta-bloccanti con liberazione controllata del principio attivo per la somministrazione orale.
AR036877A1 (es) Formulacion farmaceutica
PL317996A1 (en) Carbamazepinic form of a drug with retarded release of biologically active substance
CO4960663A1 (es) Fumarato de 2-(-3-(4-(2-t-butil-6-trifluorometilpirimidin- 4-il)piperazin-1-il) propilmecapto)pirimidin-4-ol
NZ514279A (en) Intraruminal device for dispensing medication where device has arms that open to keep the device in the animal's rumen after a constraint device dissolves
PL350413A1 (en) Pharmaceutical effervescent formulation containing metamizol
James Ritonavir capsule manufacturing problems will require switch to liquid formulation
James Viagra: new warning with protease inhibitors

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 735865

Country of ref document: ES